Prostacyclin, high density lipoproteins, and myocardial ischemia.
Open accessThe claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Functionality rather than cholesterol content of HDL has been viewed as a better predictor of CVD risk based on anti-inflammatory, anti-oxidant and endothelial restorative properties of HDL.
“As such, functionality rather than the cholesterol content of HDL has been viewed as a better predictor of CVD risk based on the well-established anti-inflammatory, anti-oxidant and endothelial restorative properties of HDL.36”
From Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor?: New Insights From the Framingham Offspring Study (2016) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Radomski, M. W., Palmer, R. M. J., & Moncada, S. (1987) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1987.tb11367.x · Cited by 1,158 · see citing works
Moncada, S., Gryglewski, R. J., Bunting, S., & Vane, J. R. (1976) · Prostaglandins · doi:10.1016/0090-6980(76)90048-4 · Cited by 604 · see citing works
The discovery of nitric oxide as the endogenous nitrovasodilator.
Moncada, S., Palmer, R. M. J., & Higgs, E. A. (1988) · Hypertension · doi:10.1161/01.hyp.12.4.365 · Cited by 493 · see citing works
Effect of Cholesterol on Production of Thromboxane B2by Platelets in Vitro
Stuart, M. J., Gerrard, J. M., & White, J. G. (1980) · New England Journal of Medicine · doi:10.1056/nejm198001033020102 · Cited by 322 · see citing works
Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta
Andrews, H. E., Bruckdorfer, K. R., DUNN, R. C., & Jacobs, M. (1987) · Nature · doi:10.1038/327237a0 · Cited by 300 · see citing works
Lefer, A. M., Ogletree, M. L., Smith, J. B., Silver, M. J., Nicolaou, K. C., Barnette, W. E., & Gasic, G. P. (1978) · Science · doi:10.1126/science.345441 · Cited by 242 · see citing works
Self-citationYui, Y., Aoyama, T., Morishita, H., Takahashi, M., Takatsu, Y., & Kawai, C. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113682 · Cited by 200 · see citing works
Studies on the protective effect of prostacyclin in acute myocardial ischemia
Ogletree, M. L., Lefer, A. M., Smith, J. B., & Nicolaou, K. C. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90438-2 · Cited by 156 · see citing works
Self-citationLack of endothelium-dependent relaxation in coronary resistance arteries of cholesterol-fed rabbits
Osborne, J. A., Siegman, M. J., Sedar, A. W., Mooers, S. U., & Lefer, A. M. (1989) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1989.256.3.c591 · Cited by 152 · see citing works
Self-citationPomerantz, K. B., & Hajjar, D. P. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.4.413 · Cited by 104 · see citing works
Antibodies which antagonise the effects of prostacyclin
Smith, J. B., Ogletree, M. L., Lefer, A. M., & Nicolaou, K. C. (1978) · Nature · doi:10.1038/274064a0 · Cited by 68 · see citing works
Self-citationMeasurement of circulating prostacyclin
Haslam, R. J., & McClenaghan, M. D. (1981) · Nature · doi:10.1038/292364a0 · Cited by 64 · see citing works
Schrör, K., Darius, H., Addicks, K., Köster, R., & Smith, E. F. (1982) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198209000-00008 · Cited by 38 · see citing works
Prostacyclin infusion in patients with acute myocardial infarction.
Henriksson, P., Edhag, O., & Wennmalm, Å. (1985) · Heart · doi:10.1136/hrt.53.2.173 · Cited by 36 · see citing works
Darius, H., OSBORNE, J., REIBEL, D., & Lefer, D. J. (1987) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(87)80591-6 · Cited by 34 · see citing works
Hieda, N., Toki, Y., Sugiyama, S., Ito, T., Satake, T., & OZAWA, T. (1988) · Cardiovascular Research · doi:10.1093/cvr/22.3.219 · Cited by 18 · see citing works
Prostaglandins Modulate Arterial Cholesteryl Ester Metabolism
Hajjar, D. P. (2017) · Enzyme · doi:10.1159/000469481 · Cited by 14 · see citing works
Flagged first, then by citations
Research works printed but not linked: 8
- Moncada S, Vane JR: Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacy- clin. Pharmacol Rev 1978;30:293
- Aoyama T, Yui Y, Morishita H, Kawai C: Prostacyclin stabi- lization by high density lipoprotein is decreased in acute myocardial infarction and unstable angina pectoris. Circulation 1990;81:1784-1791
- Eldor A, Falcone DJ, Hajjar DP, Minick CR, Weksler BB: Diet-induced hypercholesterolemia inhibits the recovery of prostacyclin production by injured rabbit aorta. Am J Pathol 1982;107:186-190
- Jugdutt BI, Hutchins GM, Bulkley BH, Lewis LC: Dissimilar effects of prostacyclin, prostaglandin El, and prostaglandin E2 on myocardial infarct size after coronary occlusion in con- scious dogs. Circ Res 1981;49:685-700
- Romson JL, Haack DW, Abrams GD, Lucchesi BR: Preven- tion of occlusive coronary artery thrombosis by prostacyclin infusion in the dog. Circulation 1981;64:906-914
- Lefer AM, Smith EF III: Protective action of prostacyclin in myocardial ischemia and trauma, in Vane JR, Bergstrom S (eds): Prostacyclin. New York, Raven Press, Publishers, 1979, pp 339-347
- Lefer AM: Role of thromboxanes in myocardial ischemia and sudden death, in McConn R (ed): Role of Chemical Mediators in the Pathophysiology ofAcute Illness and Injury. New York, Raven Press, Publishers, 1982, pp 101-109
- Willis AL, Smith DL: Therapeutic impact of eicosanoids in atherosclerotic disease. Eicosanoids 1989;2:69-99
Cited by
Sorted by citations
Wang, X., Ouyang, Y., Liu, J., Zhu, M., Zhao, G., Bao, W., & Hu, F. B. (2014) · BMJ · doi:10.1136/bmj.g4490 · Cited by 1,596 · see citing works
Wallace, T. C., Bailey, R. L., Blumberg, J. B., Burton-Freeman, B., Chen, C.-Y. O., Crowe-White, K. M., Drewnowski, A., Hooshmand, S., Johnson, E., Lewis, R., et al. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1632258 · Cited by 638 · see citing works
Miller, V., Mente, A., Dehghan, M., Rangarajan, S., Zhang, X., Swaminathan, S., Dagenais, G. R., Gupta, R., Mohan, V., Lear, S. A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32253-5 · Cited by 656 · see citing works
Vitamin C and Cardiovascular Disease: A Review
Simon, J. A. (1992) · Journal of the American College of Nutrition · doi:10.1080/07315724.1992.12098232 · Cited by 215 · see citing works
Gan, Y., Tong, X., Li, L., Cao, S., Yin, X., Gao, C., Herath, C., Li, W., Jin, Z., Chen, Y., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.01.077 · Cited by 173 · see citing works
Therapeutic potential of vitamin E in the pathogenesis of spontaneous atherosclerosis
Janero, D. R. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90193-7 · Cited by 166 · see citing works
Nagura, J., Iso, H., Watanabe, Y., Maruyama, K., Date, C., Toyoshima, H., Yamamoto, A., Kikuchi, S., Koizumi, A., Kondo, T., et al. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114508143586 · Cited by 165 · see citing works
Yokoyama, A., Date, C., Kokubo, Y., Yoshiike, N., Matsumura, Y., & Tanaka, H. (2000) · Stroke · doi:10.1161/01.str.31.10.2287 · Cited by 121 · see citing works
Bartlett, J., Predazzi, I. M., Williams, S. M., Bush, W. S., Kim, Y., Havas, S., Toth, P. P., Fazio, S., & Miller, M. (2016) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.002436 · Cited by 96 · see citing works
Serum Ascorbic Acid and Cardiovascular Disease Prevalence in U.S. Adults
Simon, J. A., Hudes, E. S., & Browner, W. S. (1998) · Epidemiology · doi:10.1097/00001648-199805000-00017 · Cited by 71 · see citing works
Chen, L. Y., & Mehta, J. L. (1994) · Life Sciences · doi:10.1016/0024-3205(94)90092-2 · Cited by 60 · see citing works
Serum Ascorbic Acid and Cardiovascular Disease Prevalence in U.S. Adults
Simon, J. A., & Hudes, E. S. (1999) · Annals of Epidemiology · doi:10.1016/s1047-2797(99)00008-3 · Cited by 48 · see citing works
Yogeeta, S. K., Raghavendran, H. R. B., Arunachalam, G., Subhashini, R., & Devaki, T. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.04.018 · Cited by 45 · see citing works
Mehta, J., & Chen, L. Y. (1996) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(96)90097-9 · Cited by 31 · see citing works
Wikström, K., Reid, H. M., Hill, M., English, K. A., O’Keeffe, M. B., Kimbembe, C. C., & Kinsella, B. T. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.09.003 · Cited by 30 · see citing works
Yogeeta, S. K., Arunachalam, G., Senthilkumar, S., Subhashini, R., & Devaki, T. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.09.012 · Cited by 26 · see citing works
Seasonal variation in parameters related to coronary heart disease risk in young men
Mustad, V. A., Derr, J., Reddy, C. C., Pearson, T. A., & Kris-Etherton, P. M. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05900-x · Cited by 23 · see citing works
Metias, E. F., Abo-Elmaaty, N., & Hussein, A. M. (2016) · Biochemistry & Physiology Open Access · doi:10.4172/2168-9652.1000210 · Cited by 19 · see citing works
HYPERALPHALIPOPROTEINEMIA AND PROSTAGLANDIN I2 STABILITY
Pirich, C., Efthimiou, Y., O’Grady, J., & Sinzinger, H. (1997) · Thrombosis Research · doi:10.1016/s0049-3848(97)00189-8 · Cited by 18 · see citing works
Turner, E. C., & Kinsella, B. T. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.12.030 · Cited by 14 · see citing works
Jones, S. P., Girod, W. G., Marotti, K. R., Aw, T. Y., & Lefer, D. J. (2001) · Coronary Artery Disease · doi:10.1097/00019501-200102000-00006 · Cited by 13 · see citing works
Prevention of coronary heart disease Part I. Primary prevention
Liesbon, P. R., & Amsterdam, E. A. (1999) · Disease-a-Month · doi:10.1016/s0011-5029(99)90016-0 · Cited by 11 · see citing works
Sequential release of eicosanoids during endotoxin-induced shock in anesthetized pigs
Mózes, T., Zijlstra, F. J., Heiligers, J. P. C., Saxena, P. R., & Bonta, I. L. (1991) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(91)90085-j · Cited by 11 · see citing works
Geravand, F., Montazer, M., Mousavi, S. M., & Azadbakht, L. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuaf013 · Cited by 9 · see citing works
Keating, G. L., Turner, E. C., & Kinsella, B. T. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2012.02.010 · Cited by 7 · see citing works
Mózes, T., Zijlstra, F. J., & Heiligers, J. P. C. (1992) · Mediators of Inflammation · doi:10.1155/s0962935192000280 · Cited by 7 · see citing works
Lee, W. J. (2019) · Springer eBooks · doi:10.1007/978-94-024-1713-5_2 · Cited by 2 · see citing works
Omega-3s and Immune/Inflammatory Responses
Nettleton, J. A. (1995) · Springer eBooks · doi:10.1007/978-1-4615-2071-9_5 · Cited by 2 · see citing works
Plasma protein binding and biologic half-life of prostacyclin in steady state sickle cell disease
Longenecker, L., McNeil, A., & Longenecker, G. L. (1991) · Thrombosis Research · doi:10.1016/0049-3848(91)90075-8 · Cited by 2 · see citing works
Simon, J. A., Packer, L., Traber, M. G., Kraemer, K., & Frei, B. B. (2002) · Cited by 2 · see citing works
Serum Ascorbic Acid and Disease Prevalence in U.S. Adults
Simon, J. (2003) · AOCS Publishing eBooks · doi:10.1201/9781439822173.ch6 · Cited by 1 · see citing works
Impaired PGI2-Stabilization in Septic Shock Patients
Podolsky, A., Vichytil, A., Pidlich, J., & Sinzinger, H. F. (1992) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7262-1_28 · Cited by 1 · see citing works
Igumbor, B. A. (2017) · ResearchSpace (University of KwaZulu-Natal)
- Authors
- Lefer, A. M.
- Affiliations
- Thomas Jefferson University (US)
- Corresponding author
- Lefer, A M
- Venue
- Circulation
- Published
- 1990-06
- Volume
- 81
- Issue
- 6
- Pages
- 2013-2015
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1971874842
- Cited by
- 33
- References
- 17
- Citations by year
- 2025: 1 · 2019: 2 · 2017: 2 · 2016: 2 · 2015: 1 · 2014: 1 · 2012: 1
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Keywords
- prostacyclin, high-density lipoprotein, myocardial ischemia, coronary artery disease, lipoproteins, prostaglandins
- MeSH terms
- Coronary Disease, Humans, Lipoproteins, HDL, Epoprostenol, Thromboxane A2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review